
Thea D' Ambrosio
Examiner (ID: 2073, Phone: (571)270-1216 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1675, 1654 |
| Total Applications | 599 |
| Issued Applications | 266 |
| Pending Applications | 113 |
| Abandoned Applications | 241 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13368991
[patent_doc_number] => 20180236036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-23
[patent_title] => USE OF THYMOSIN ALPHA FOR THE TREATMENT OF SEPSIS
[patent_app_type] => utility
[patent_app_number] => 15/710012
[patent_app_country] => US
[patent_app_date] => 2017-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17415
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15710012
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/710012 | USE OF THYMOSIN ALPHA FOR THE TREATMENT OF SEPSIS | Sep 19, 2017 | Abandoned |
Array
(
[id] => 13702683
[patent_doc_number] => 20170362296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => PEPTIDES BASED ON THE TRANSMEMBRANE DOMAIN OF A TOLL-LIKE RECEPTOR (TLR) FOR TREATMENT OF TLR-MEDIATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/696206
[patent_app_country] => US
[patent_app_date] => 2017-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15003
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15696206
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/696206 | PEPTIDES BASED ON THE TRANSMEMBRANE DOMAIN OF A TOLL-LIKE RECEPTOR (TLR) FOR TREATMENT OF TLR-MEDIATED DISEASES | Sep 5, 2017 | Abandoned |
Array
(
[id] => 14883541
[patent_doc_number] => 10421797
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-24
[patent_title] => Short peptide-based therapeutic agent and medicinal composition including the same for inhibiting activities of cancer cells
[patent_app_type] => utility
[patent_app_number] => 15/696197
[patent_app_country] => US
[patent_app_date] => 2017-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 7839
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15696197
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/696197 | Short peptide-based therapeutic agent and medicinal composition including the same for inhibiting activities of cancer cells | Sep 5, 2017 | Issued |
Array
(
[id] => 15512725
[patent_doc_number] => 10562938
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-18
[patent_title] => Theragnostic particles
[patent_app_type] => utility
[patent_app_number] => 15/692909
[patent_app_country] => US
[patent_app_date] => 2017-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 13
[patent_no_of_words] => 24533
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15692909
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/692909 | Theragnostic particles | Aug 30, 2017 | Issued |
Array
(
[id] => 17922831
[patent_doc_number] => 11466064
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-11
[patent_title] => Bcl-w polypeptides and mimetics for treating or preventing chemotherapy-induced peripheral neuropathy and hearing loss
[patent_app_type] => utility
[patent_app_number] => 16/326493
[patent_app_country] => US
[patent_app_date] => 2017-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 15
[patent_no_of_words] => 28443
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16326493
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/326493 | Bcl-w polypeptides and mimetics for treating or preventing chemotherapy-induced peripheral neuropathy and hearing loss | Aug 24, 2017 | Issued |
Array
(
[id] => 12057179
[patent_doc_number] => 20170333523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'Whey Protein Micelles to Enhance Muscle Mass and Performance'
[patent_app_type] => utility
[patent_app_number] => 15/673630
[patent_app_country] => US
[patent_app_date] => 2017-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3293
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15673630
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/673630 | Whey Protein Micelles to Enhance Muscle Mass and Performance | Aug 9, 2017 | Abandoned |
Array
(
[id] => 13761171
[patent_doc_number] => 10172914
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-08
[patent_title] => Combination
[patent_app_type] => utility
[patent_app_number] => 15/672841
[patent_app_country] => US
[patent_app_date] => 2017-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23464
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15672841
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/672841 | Combination | Aug 8, 2017 | Issued |
Array
(
[id] => 16642133
[patent_doc_number] => 10919969
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-16
[patent_title] => Anti-CD123 antibodies and conjugates and derivatives thereof
[patent_app_type] => utility
[patent_app_number] => 15/667697
[patent_app_country] => US
[patent_app_date] => 2017-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 54
[patent_no_of_words] => 62484
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 217
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15667697
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/667697 | Anti-CD123 antibodies and conjugates and derivatives thereof | Aug 2, 2017 | Issued |
Array
(
[id] => 14911083
[patent_doc_number] => 10426841
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-01
[patent_title] => Combination of drugs with protein-binding prodrugs
[patent_app_type] => utility
[patent_app_number] => 15/650305
[patent_app_country] => US
[patent_app_date] => 2017-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5427
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15650305
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/650305 | Combination of drugs with protein-binding prodrugs | Jul 13, 2017 | Issued |
Array
(
[id] => 18576714
[patent_doc_number] => 11733234
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-22
[patent_title] => Compositions and methods of cell attachment
[patent_app_type] => utility
[patent_app_number] => 15/648339
[patent_app_country] => US
[patent_app_date] => 2017-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 49
[patent_no_of_words] => 13645
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15648339
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/648339 | Compositions and methods of cell attachment | Jul 11, 2017 | Issued |
Array
(
[id] => 18014364
[patent_doc_number] => 11506653
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-22
[patent_title] => Compositions and methods of cell attachment
[patent_app_type] => utility
[patent_app_number] => 15/648352
[patent_app_country] => US
[patent_app_date] => 2017-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 49
[patent_no_of_words] => 13657
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15648352
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/648352 | Compositions and methods of cell attachment | Jul 11, 2017 | Issued |
Array
(
[id] => 12152852
[patent_doc_number] => 20180024116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-25
[patent_title] => 'COMPOSITIONS AND METHODS OF CELL ATTACHMENT'
[patent_app_type] => utility
[patent_app_number] => 15/648213
[patent_app_country] => US
[patent_app_date] => 2017-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 14291
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15648213
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/648213 | Compositions and methods of cell attachment | Jul 11, 2017 | Issued |
Array
(
[id] => 12152854
[patent_doc_number] => 20180024118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-25
[patent_title] => 'COMPOSITIONS AND METHODS OF CELL ATTACHMENT'
[patent_app_type] => utility
[patent_app_number] => 15/648306
[patent_app_country] => US
[patent_app_date] => 2017-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 14291
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15648306
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/648306 | Compositions and methods of cell attachment | Jul 11, 2017 | Issued |
Array
(
[id] => 18014363
[patent_doc_number] => 11506652
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-22
[patent_title] => Compositions and methods of cell attachment
[patent_app_type] => utility
[patent_app_number] => 15/648293
[patent_app_country] => US
[patent_app_date] => 2017-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 49
[patent_no_of_words] => 13649
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15648293
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/648293 | Compositions and methods of cell attachment | Jul 11, 2017 | Issued |
Array
(
[id] => 12152856
[patent_doc_number] => 20180024119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-25
[patent_title] => 'COMPOSITIONS AND METHODS OF CELL ATTACHMENT'
[patent_app_type] => utility
[patent_app_number] => 15/648319
[patent_app_country] => US
[patent_app_date] => 2017-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 14298
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15648319
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/648319 | Compositions and methods of cell attachment | Jul 11, 2017 | Issued |
Array
(
[id] => 14836197
[patent_doc_number] => 20190276499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => Protein VII Fragments and Methods of Use Thereof for the Treatment of Inflammatory Disorders
[patent_app_type] => utility
[patent_app_number] => 16/312010
[patent_app_country] => US
[patent_app_date] => 2017-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19033
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16312010
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/312010 | Protein VII Fragments and Methods of Use Thereof for the Treatment of Inflammatory Disorders | Jun 21, 2017 | Abandoned |
Array
(
[id] => 12680863
[patent_doc_number] => 20180118787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => COMPSTATIN ANALOGS FOR TREATMENT OF RHINOSINUSITIS AND NASAL POLYPOSIS
[patent_app_type] => utility
[patent_app_number] => 15/623594
[patent_app_country] => US
[patent_app_date] => 2017-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23477
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15623594
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/623594 | COMPSTATIN ANALOGS FOR TREATMENT OF RHINOSINUSITIS AND NASAL POLYPOSIS | Jun 14, 2017 | Abandoned |
Array
(
[id] => 12030868
[patent_doc_number] => 20170320968
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'METHODS AND PRODUCTS FOR INCREASING FRATAXIN LEVELS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/620168
[patent_app_country] => US
[patent_app_date] => 2017-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 67
[patent_figures_cnt] => 67
[patent_no_of_words] => 16464
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15620168
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/620168 | METHODS AND PRODUCTS FOR INCREASING FRATAXIN LEVELS AND USES THEREOF | Jun 11, 2017 | Abandoned |
Array
(
[id] => 12137058
[patent_doc_number] => 20180015142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'THERAPEUTIC AND PROPHYLACTIC METHODS, USES AND COMPOSITIONS COMPRISING ANEXIN A5'
[patent_app_type] => utility
[patent_app_number] => 15/606623
[patent_app_country] => US
[patent_app_date] => 2017-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7478
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15606623
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/606623 | THERAPEUTIC AND PROPHYLACTIC METHODS, USES AND COMPOSITIONS COMPRISING ANEXIN A5 | May 25, 2017 | Abandoned |
Array
(
[id] => 11954753
[patent_doc_number] => 20170258904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'Antagonism of the VIP Signaling Pathway'
[patent_app_type] => utility
[patent_app_number] => 15/601352
[patent_app_country] => US
[patent_app_date] => 2017-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11803
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15601352
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/601352 | Antagonism of the VIP signaling pathway | May 21, 2017 | Issued |